Value through InnovationSeptember 18 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim press releases. To quickly find all press releases on a specific topic, please use the search.

Press Release Archive

back 1 2 3 4 5 6 7 8 9 10
09.18.2014

Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy

- For U.S. Media
09.16.2014

Boehringer Ingelheim Named to Working Mother’s “100 Best Companies for Working Mothers” List

09.10.2014

European Commission grants Lilly and Boehringer Ingelheim’s insulin glargine product marketing authorisation in Europe

- For U.S. Media Only
09.10.2014

To Mark Pulmonary Fibrosis Awareness Month, Boehringer Ingelheim Announces Discovery Channel Documentary on Idiopathic Pulmonary Fibrosis

09.09.2014

New Analysis of Phase III Trials Examines the Impact of Boehringer Ingelheim’s IPF Therapy Nintedanib on Lung Function Decline Based on Patients’ Baseline Severity

- For U.S. Media Only
09.08.2014

Boehringer Ingelheim Presents Pivotal Phase III Data for the Investigational Fixed-Dose Combination of Tiotropium + Olodaterol in COPD

- For U.S. Media Only
09.08.2014

New Phase III Study Shows Investigational Tiotropium Improves Lung Function in Adolescent Patients with Symptomatic Asthma

- For U.S. Media Only
09.02.2014

ESC Hot Line: Data Reports NVAF Patients Taking Pradaxa® (dabigatran etexilate mesylate) Experienced Slower Decline in Kidney Function Compared to Those on Warfarin

08.26.2014

New type 2 diabetes treatment Jardiance® (empagliflozin) tablets for adults now available in U.S. pharmacies

- For U.S. media
08.25.2014

Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at European Society of Cardiology Congress 2014

back 1 2 3 4 5 6 7 8 9 10